The largest-ever U.K. trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment. Led by researchers at the University of Manchester and Manchester University NHS Foundation Trust (MFT), the study investigated the efficacy of a urine test that detects the presence or absence of blood pressure-lowering medications—known as chemical adherence testing, or CAT.